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4 (16%) one month after discharge from hospital. Underlying disease was coro-
nary artery disease (CAD) (62%) including previous myocardial infarction (83%
of patients with CAD), hypertensive heart disease (18%), rheumatic valvular dis-
ease (13%) and primitive dilated cardiomyopathy (7%). Cardiovascular risk fac-
tors were tobacco use (53%), hypertension (69%), diabetes (47%) and
hypercholesterolemia (51%). In the CAD group, patients were older and diabetes
was more frequent (p<0.01). Khat chewers (53%) were all males and smokers.
Severe renal failure was found in 20%. Mean left ventricular ejection fraction
(LVEF) was 39±14%. Atrial fibrillation was observed in 7%. During follow up
(14.4±9 months), 8 (18%) patients died, 9 (20%) had new hospitalization for HF
and 3 (7%) had an ischemic stroke. Higher NYHA classes were associated with
poorer outcomes (p= 0.03). Patients with LVEF 35% (n=24, 53%), were com-
pared with patients with LVEF >35% and no difference was observed in terms of
risk factors, underlying disease and outcome.
Conclusion: In hospitalized Djiboutian, most of HF patterns are similar to
those of industrialized countries. CAD is more prevalent than previously reported
in African patients with HF. Epidemiologic transition is a reality in Djibouti.
Urgent measures for the prevention of cardiovascular disease and HF are needed.
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Approximately 20% of heart failure patients have low levels of serum
sodium, often at a time when they are hospitalized during a period of decom-
pensation. It may reflect worsening heart failure and the deleterious effects of
activation of neurohormones. However, impact of hypernatremia, prognosti-
cally relevant cut-off values, and differential prognosis with reference range
serum sodium levels are not well defined.
Methods: Our aim was to prospectively assess the impact of baseline
natremia and changes in sodium level during median follow-up of 32 months
in 1509 patients. According to our central laboratory, hypo- and hyper-
natremia were defined as sodium levels <135 and >145 mmol/l. Chi2 test was
used, a difference was statistically considered significant if p<0.05.
Results: The prevalence of Hyponatremia was 12.45% and hypernatremia
was 0.9%. The mean age was 64.32 years (20-97), with a male predominance
(68.15%).There was a correlation between value of sodium levels and severity
of heart failure. The positive correlates of hyponatremia compared with nor-
monatremia were NYHA functional class [we find class III in 32.9% patients
vs 18.5% (p=0.0089) and class IV in 7.9% vs 2.09% (p=0.0075)], decompen-
sation found in 26.5% patients vs 12.04% (p=0.0085), renal dysfunction: mean
creatinine was at 15 vs 10mg per litre (p=0.0015), use of high dose of
diuretics 61.17% vs 40.46% (p=0.0012) and use of spironolactone 81,38% vs
51,50%(p=0.0082). Positive correlates of hypernatremia were intake of
diuretics 54.8% vs 40.46% (p=0.001), NYHA functional class [72.78% were
in class II vs 61.03% and 27.22% were in class III vs 18.5% (p=0.002 )], dec-
ompensation in 38.8% vs 12.04% (p=0;001)
Conclusion: The severity of heart failure, the renal function and medication
were associated with serum sodium levels. Our data indicate the need of further
research into optimized management of sodium-water homeostasis in heart failure.
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Introduction: Renal dysfunction (RD) is common in patients with chronic
heart failure (CHF) and predicts a worse outcome The aim of our study is to
determine the prevalence and incidence of renal dysfunction (RD) in patients
with chronic heart failure (CHF), to compare the clinical characteristics of
patients with different severities of RD and to identify contributory factors and
predictors of worsening renal function (WRF).
Material And Methods: This was a single centre, observational and
comparative study. We included 1500 patients followed for CHF with left
ventricular ejection fraction 45% in Ibn Rochd Center of Cardiology from
May 2006 to October 2010. The glomerular filtration rate (GFR) calculated by
the simplified modification of diet in renal disease (MDRD) was used to deter-
mine renal function . We divided patients in four groups based upon the base-
line GFR (normal 90 mL/min, mild impairment 60-89 mL/min, moderate
impairment 30-59 mL/min, and severe renal impairment 29 mL/min). WRF
was defined as an increase in serum creatinine of >26.5 mmol/L (>0.3 mg/dL).
Results: The mean age of our patients was 63±12.14 years (16-100), and
67% were men. Mean ejection fraction was 33%. GFR was normal (90 mL/min)
in only 150 patients (10%), mildly reduced (60-89 mL/min) in 525 patients
(35%), moderately reduced (30-59 ml/min) in 645 patients (43%), and mark-
edly reduced (29 ml/min) in 180 patients (12%). Patients with severely
impaired renal function were older, more often male and had lower left ven-
tricular ejection fractions, and haemoglobin levels than patients with normal
or mildly impaired renal function.
During 12 months, WRF occurred in 390 (26%) patients. Predictors of
WRF were renal dysfunction at baseline, diabetes, NYHA classes III-IV, and
systolic blood pressure > 140mmhg.
Conclusion: In patients with CHF, RD is common, commonly deteriorates
over a relatively short period of time and associated with poor prognosis.
Better knowledge of predictors of worsening renal function, allows selecting
groups at high risk where néphroprotective measures must be strengthened.
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Background: Left ventricular non compaction (LVNC) is a recently rec-
ognized genetic cardiomyopathy. Many studies demonstrated areas of myocar-
dial fibrosis in patients with LVNC. However, there is still many uncertainties
related to the pattern of fibrosis especially in North African patients.
Methods: In our retrospective cohort, twelve patients (7 male, mean age 53+/
–8 years) underwent magnetic resonance imaging (cine and delayed enhancement
sequences) for suspected LVNC. The diagnosis of isolated LVNC was based on
Petersen criteria. For each patient, the distribution of non-compaction was assessed
by qualitative analysis of all seventeen left ventricular segments, according to stan-
dard seventeen-segment cardiac model. The presence or absence of late gado-
linium enhancement (LGE), a surrogate of fibrosis, was qualitatively determined
for each left ventricular myocardial segment.
Results: Non compaction was more commonly observed at the apex, the
anterior wall and the lateral wall, especially on their apical and mid-cavity
segments. A total of four (33%) patients showed LGE. All those patients had
impaired left ventricular ejection fraction. Myocardial fibrosis was mid-myo-
cardial in two cases and sub-endocardial in the remaining ones. Overall, LGE
was seen in twenty-two LV segments, thirteen (59%) of which were com-
pacted segments, while the others (41%) were non-compacted. No association
was found between the pattern of fibrosis and non compaction distribution
(OR=2,2, CI [0,91-5,55], p=0,076).
Conclusion: In North African population with LVNC, myocardial fibrosis is
observed in non compacted and compacted segments with a similar prevalence.
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Background: Prognostic value of signs of congestion in chronic heart
failure (CHF) is unknown.
